Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Deloitte
Teva
Fish and Richardson
Argus Health
Daiichi Sankyo
Johnson and Johnson
Fuji
QuintilesIMS
Chubb

Generated: October 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207917

« Back to Dashboard
NDA 207917 describes EPIDUO FORTE, which is a drug marketed by Galderma Labs and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug and one Paragraph IV challenge. Additional details are available on the EPIDUO FORTE profile page.

The generic ingredient in EPIDUO FORTE is adapalene; benzoyl peroxide. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the adapalene; benzoyl peroxide profile page.

Summary for NDA: 207917

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:8
Formulation / Manufacturing:see details

Pharmacology for NDA: 207917

Ingredient-typeRetinoids

Suppliers and Packaging for NDA: 207917

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EPIDUO FORTE
adapalene; benzoyl peroxide
GEL;TOPICAL 207917 NDA Galderma Laboratories, L.P. 0299-5906 0299-5906-02 1 TUBE in 1 BLISTER PACK (0299-5906-02) > 2 g in 1 TUBE
EPIDUO FORTE
adapalene; benzoyl peroxide
GEL;TOPICAL 207917 NDA Galderma Laboratories, L.P. 0299-5906 0299-5906-05 1 TUBE in 1 BLISTER PACK (0299-5906-05) > 5 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength0.3%;2.5%
Approval Date:Jul 15, 2015TE:RLD:Yes
Regulatory Exclusivity Expiration:Jul 15, 2018
Regulatory Exclusivity Use:NEW PRODUCT
Patent:► SubscribePatent Expiration:Dec 23, 2022Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF ACNE
Patent:► SubscribePatent Expiration:Mar 12, 2023Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF ACNE


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Novartis
Cerilliant
Fuji
Covington
Express Scripts
Daiichi Sankyo
Chinese Patent Office
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot